Table 2.

Clinical Decisions Made in Pediatric Traumatic Brain Injury Patients Using MMM Reporting

Clinical Decision	No. of patients (%)
Timing of Neuroimaging	18/18 (100.0)
Testing of Tolerance of Lying Flat	3/18 (16.7)
Adjustment of Paralytic Therapy	2/18 (11.1)
Escalation of Therapy	2/2 (100.0)
De-Escalation of Therapy	2/2 (100.0)
Adjustment of Hyperosmolar Therapy	4/18 (22.2)
Escalation of Therapy	4/4 (100.0)
De-Escalation of Therapy	4/4 (100.0)
Adjustment of Pentobarbital Therapy	6/18 (33.3)
Escalation of Therapy	6/6 (100.0)
De-escalation of Therapy	6/6 (100.0)
Use of Provocative Autoregulation Testing	3/18 (16.7)
Adjustment of CPP Threshold	3/18 (16.7)
Lowering of CPP Threshold	2/3 (66.7)
Raising of CPP Threshold	1/3 (33.3)
Adjustment of PaCO2 goal	2/18 (11.1)
Lowering of PaCO2 Threshold	2/2 (100.0)
Raising of PaCO2 Threshold	2/2 (100.0)
Surgical Decision Making	3/18 (100.0)
EVD Placement	1/3 (33.3)
Decompressive Craniectomy	1/3 (33.3)
Intracortical Electrode Monitoring  Placement	1/3 (33.3)
Removal of Invasive Neuromonitoring	18/18 (100.0)
Timing of Extubation in Patients without Withdrawal of Life Sustaining Therapies	16/16 (100.0)
Body Repositioning for Improved Jugular Venous Return	2/18 (11.1)
Discussion of MMM Findings in Prognostication with Patient Surrogates	2/18 (11.1)

Abbreviations: %, percent; CPP, cerebral perfusion pressure; EVD, external ventricular drain; MMM, multimodal neurologic monitoring; No, number; PaCO₂, partial pressure of carbon dioxide